P-160 - SINGLE-DOSE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST APROCITENTAN IN SUBJECTS WITH MODERATE HEPATIC IMPAIRMENT.
M. Fontes1, J. Dingemanse1, A. Halabi2, M. Tomaszewska-Kiecana3, P. Sidharta1; 1Idorsia Pharmaceuticals, Allschwil, Switzerland, 2Clinical Research Services Kiel GmbH, Kiel, Germany, 3Biokinetica, Józefów, Poland.
.png)